This article talks about how people trade options in a company called Iovance Biotherapeutics. Options trading is when you can buy or sell something at a certain price by a specific date. The article says that traders need to learn a lot and pay attention to the market to be successful. It also mentions a service called Benzinga Pro that helps people stay updated on options trades for Iovance Biotherapeutics. Read from source...

1. The title is misleading and sensationalized. It should be something like "Options Trading Activity in Iovance Biotherapeutics" instead of "Unpacking the Latest Options Trading Trends".
2. The article does not provide any data or evidence to support the claim that there are new trends in options trading for IOVA. It only mentions some anecdotal examples and quotes from anonymous sources, which are not reliable sources of information. 3. The article fails to explain how options trading works and what factors influence the price of options contracts. It assumes that the readers already have a basic understanding of this complex financial instrument, which is unlikely for most of the general audience. 4. The article promotes Benzinga Pro as a service that provides real-time options trades alerts, without disclosing that it is a paid subscription and that there may be conflicts of interest between the author and the company. This is an unethical practice that violates journalistic standards and principles. 5. The article ends with a sales pitch for Benzinga Pro and other services, which is inappropriate and irrelevant for an informative article. It tries to persuade the readers to sign up for these services by using fear, urgency, and scarcity tactics, which are manipulative and dishonest.